Document is current
Any future updates will be listed below
-
Authors
Valenzuela, Sebastian https://orcid.org/0000-0001-5153-8431
Zhu, Xuefeng
Macao, Bertil
Stamgren, Mattias
Geukens, Carol
Charifson, Paul S.
Kern, Gunther
Hoberg, Emily
Jenninger, Louise
Gruszczyk, Anja V. https://orcid.org/0000-0003-3060-4107
Lee, Seoeun
Johansson, Katarina A. S. https://orcid.org/0009-0005-8992-7631
Miralles Fusté, Javier https://orcid.org/0000-0001-8818-9650
Shi, Yonghong
Kerns, S. Jordan
Arabanian, Laleh
Martinez Botella, Gabriel
Ekström, Sofie
Green, Jeremy https://orcid.org/0000-0003-4544-6412
Griffin, Andrew M.
Pardo-Hernández, Carlos
Keating, Thomas A. https://orcid.org/0009-0009-1386-2471
Küppers-Munther, Barbara
Larsson, Nils-Göran https://orcid.org/0000-0001-5100-996X
Phan, Cindy
Posse, Viktor https://orcid.org/0000-0003-4936-4967
Jones, Juli E.
Xie, Xie
Giroux, Simon https://orcid.org/0000-0003-1499-2576
Gustafsson, Claes M. https://orcid.org/0000-0003-3531-8468
Falkenberg, Maria https://orcid.org/0000-0001-8713-173X
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 3 March 2025
First Online: 9 April 2025
Competing interests
: M.F., C.M.G., G.M.B. and N.-G.L. are co-founders of Pretzel Therapeutics. M.F., C.M.G., B.M., X.Z. and N.-G.L. are shareholders of Pretzel Therapeutics and have received consulting fees. S.V. has received consulting fees from Pretzel Therapeutics. M.S., C.G., A.V.G., J.M.F., Y.S., S.J.K., L.A., G.M.B., S.E., C.P.-H., T.A.K., B.K.-M., C.P., J.E.J., X.X. and S.G. are full-time employees of Pretzel Therapeutics and may hold stock or stock options as part of their compensation. V.P. is a former employee of Pretzel Therapeutics. P.S.C., A.M.G., G.K. and J.G. are consultants for Pretzel Therapeutics and hold stock or stock options as part of their compensation. The other authors declare no competing interests.
